These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18086957)

  • 1. The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans.
    Lavi S; Yang EH; Prasad A; Mathew V; Barsness GW; Rihal CS; Lerman LO; Lerman A
    Hypertension; 2008 Jan; 51(1):127-33. PubMed ID: 18086957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation.
    Schiffrin EL
    Hypertension; 2008 Jan; 51(1):31-2. PubMed ID: 18071058
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylcholine acutely modifies nitric oxide synthase function in the human coronary circulation.
    Miner SE; Al-Hesayen A; Nield LE; Gori T; Parker JD
    Exp Physiol; 2010 Dec; 95(12):1167-76. PubMed ID: 20817701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet inhibitory effect of nitric oxide in the human coronary circulation: impact of endothelial dysfunction.
    Andrews NP; Husain M; Dakak N; Quyyumi AA
    J Am Coll Cardiol; 2001 Feb; 37(2):510-6. PubMed ID: 11216971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure.
    Mohri M; Egashira K; Tagawa T; Kuga T; Tagawa H; Harasawa Y; Shimokawa H; Takeshita A
    Hypertension; 1997 Jul; 30(1 Pt 1):50-6. PubMed ID: 9231820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina.
    Egashira K; Katsuda Y; Mohri M; Kuga T; Tagawa T; Shimokawa H; Takeshita A
    J Am Coll Cardiol; 1996 May; 27(6):1444-9. PubMed ID: 8626956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.
    Virdis A; Colucci R; Fornai M; Blandizzi C; Duranti E; Pinto S; Bernardini N; Segnani C; Antonioli L; Taddei S; Salvetti A; Del Tacca M
    J Pharmacol Exp Ther; 2005 Mar; 312(3):945-53. PubMed ID: 15547110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress.
    Clapp BR; Hingorani AD; Kharbanda RK; Mohamed-Ali V; Stephens JW; Vallance P; MacAllister RJ
    Cardiovasc Res; 2004 Oct; 64(1):172-8. PubMed ID: 15364625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vasomotor responses to isometric handgrip exercise are primarily mediated by nitric oxide: a noninvasive MRI test of coronary endothelial function.
    Hays AG; Iantorno M; Soleimanifard S; Steinberg A; Schär M; Gerstenblith G; Stuber M; Weiss RG
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1343-50. PubMed ID: 25820391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.
    Quyyumi AA; Dakak N; Andrews NP; Husain S; Arora S; Gilligan DM; Panza JA; Cannon RO
    J Clin Invest; 1995 Apr; 95(4):1747-55. PubMed ID: 7706483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beer elicits vasculoprotective effects through Akt/eNOS activation.
    Vilahur G; Casani L; Mendieta G; Lamuela-Raventos RM; Estruch R; Badimon L
    Eur J Clin Invest; 2014 Dec; 44(12):1177-88. PubMed ID: 25323945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase.
    Hornig B; Landmesser U; Kohler C; Ahlersmann D; Spiekermann S; Christoph A; Tatge H; Drexler H
    Circulation; 2001 Feb; 103(6):799-805. PubMed ID: 11171786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects.
    Heitzer T; Rudolph V; Schwedhelm E; Karstens M; Sydow K; Ortak M; Tschentscher P; Meinertz T; Böger R; Baldus S
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1648-52. PubMed ID: 16675725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-arginine transport in the human coronary and peripheral circulation.
    Miner SE; Al-Hesayen A; Kelly S; Benson T; Thiessen JJ; Young VR; Parker JD
    Circulation; 2004 Mar; 109(10):1278-83. PubMed ID: 15007014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Important role of endogenous hydrogen peroxide in pacing-induced metabolic coronary vasodilation in dogs in vivo.
    Yada T; Shimokawa H; Hiramatsu O; Shinozaki Y; Mori H; Goto M; Ogasawara Y; Kajiya F
    J Am Coll Cardiol; 2007 Sep; 50(13):1272-8. PubMed ID: 17888845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers.
    Kugiyama K; Yasue H; Ohgushi M; Motoyama T; Kawano H; Inobe Y; Hirashima O; Sugiyama S
    J Am Coll Cardiol; 1996 Nov; 28(5):1161-7. PubMed ID: 8890810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin improves diabetes-induced coronary endothelial dysfunction.
    Tawfik HE; El-Remessy AB; Matragoon S; Ma G; Caldwell RB; Caldwell RW
    J Pharmacol Exp Ther; 2006 Oct; 319(1):386-95. PubMed ID: 16849625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.
    Bellien J; Iacob M; Remy-Jouet I; Lucas D; Monteil C; Gutierrez L; Vendeville C; Dreano Y; Mercier A; Thuillez C; Joannides R
    Circulation; 2012 Mar; 125(10):1266-75. PubMed ID: 22412088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiology of coronary spasm].
    Kugiyama K; Yasue H
    Nihon Rinsho; 1998 Oct; 56(10):2483-7. PubMed ID: 9796306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.